In October 2023, Which of the following malaria vaccine has recommended for use by WHO?

B. S/AS01
C. R21
D. None of these


Correct Answer: C. R21

Detail about MCQs

The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant technology, has been recommended for use by the World Health Organisation (WHO) after meeting required safety, quality and effectiveness standards, on Monday.

Write a Comment

Your email address will not be published. Required fields are marked *